Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Change in Receivables: 2019-2025

Historic Change in Receivables for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to -$197,000.

  • Benitec Biopharma's Change in Receivables fell 83.52% to $29,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $25,000, marking a year-over-year decrease of 85.12%. This contributed to the annual value of -$197,000 for FY2025, which is 211.93% down from last year.
  • Per Benitec Biopharma's latest filing, its Change in Receivables stood at -$197,000 for FY2025, which was down 211.93% from $176,000 recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Change in Receivables ranged from a high of $176,000 in FY2024 and a low of -$197,000 during FY2025.
  • Moreover, its 3-year median value for Change in Receivables was $50,000 (2023), whereas its average is $9,667.
  • Its Change in Receivables has fluctuated over the past 5 years, first skyrocketed by 5,100.00% in 2023, then crashed by 211.93% in 2025.
  • Over the past 5 years, Benitec Biopharma's Change in Receivables (Yearly) stood at -$28,000 in 2021, then spiked by 96.43% to -$1,000 in 2022, then skyrocketed by 5,100.00% to $50,000 in 2023, then soared by 252.00% to $176,000 in 2024, then plummeted by 211.93% to -$197,000 in 2025.